Positivity of high-sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non-HBV-related HCC,Alimentary Pharmacology & Therapeutics

当前位置： X-MOL 学术 › Aliment. Pharm. Ther. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Positivity of high-sensitivity HBsAg test, not previous HBV infection, indicates poor prognosis in patients with non-HBV-related HCC
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2024-09-04 , DOI: 10.1111/apt.18229
Naohiro Yasuura ₁ , Goki Suda ₁ , Masatsugu Ohara ₁ , Akimitsu Meno ₁ , Takuya Sho ₁ , Risako Kohya ₁ , Takashi Sasaki ₁ , Tomoka Yoda ₁ , Sonoe Yoshida ₁ , Qingjie Fu ₁ , Zijian Yang ₁ , Shunichi Hosoda ₁ , Osamu Maehara ₂ , Shunsuke Ohnishi ₂ , Tomoya Saitou ₃ , Masaya Sugiyama ₄ , Takasuke Fukuhara ₅ , Masaru Baba ₆ , Takashi Kitagataya ₁ , Naoki Kawagishi ₁ , Masato Nakai ₁ , Mitsuteru Natsuizaka ₁ , Koji Ogawa ₁ , Akinobu Taketomi ₃ , Naoya Sakamoto ₁

Affiliation

The prognostic impact of previous-HBV-infection (pHBV) in non-HBV-related hepatocellular carcinoma (non-HBV-related-HCC) and the prevalence, characteristics and significance of recently developed high-sensitivity HBs antigen positivity (hHBsAg+) in these patients remain unclear. We aimed to close these gaps.

中文翻译：

高敏 HBsAg 检测阳性，而不是既往 HBV 感染，提示非 HBV 相关 HCC 患者的预后不良

既往 HBV 感染（pHBV）对非 HBV 相关肝细胞癌（non-HBV related-HCC）的预后影响以及这些患者近期发生的高敏 HBs 抗原阳性（hHBsAg+）的患病率、特征和意义仍不清楚。我们的目标是缩小这些差距。

更新日期：2024-09-04

点击分享查看原文

点击收藏

阅读更多本刊新发论文本刊介绍/投稿指南